polycloal antibodies

Liver transplantation (LT) is indicated for the treatment of acute liver failure (ALF) and end-stage liver disease (ESLD). Currently, the overall 1-year and 5-year post-LT patient survival rates are 80-90% and 60-75%, respectively. Liver transplantation can be classified according to the type of donor, into deceased and live donor liver transplants. Liver grafts in the Western countries come predominantly from deceased donors in around 95% of the cases*. Orthotopic…